Rigel Pharmaceuticals Ownership | Who Owns Rigel Pharmaceuticals?
Rigel Pharmaceuticals Ownership Summary
2.18% insiders, and 97.81% retail investors. Barclays is the largest institutional shareholder, holding 0.01% of RIGL shares. Invesco Dorsey Wright SmallCap Momt ETF is the top mutual fund, with 6.18% of its assets in Rigel Pharmaceuticals shares.
RIGL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Rigel Pharmaceuticals | - | 2.18% | 97.81% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Barclays | 10.57K | 0.01% | $88.00K |
| Nelson, van denburg & campbell wealth management group | 356.00 | 0.00% | $5.99K |
| Versant capital management | 123.00 | 0.00% | $2.07K |
| Ifp advisors | 1.00K | 0.00% | $807.00 |
| Prudential financial | - | - | - |
| Legal & general group | - | - | - |
| Voya investment management | - | - | - |
| Hexagon capital partners | 2.00 | - | $17.00 |
| National bank of canada /fi/ | - | - | - |
| Jacobs levy equity management | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Versant capital management | 123.00 | 0.00% | $2.07K |
| Nelson, van denburg & campbell wealth management group | 356.00 | 0.00% | $5.99K |
| Voya investment management | - | - | - |
| National bank of canada /fi/ | - | - | - |
| Prudential financial | - | - | - |
| Legal & general group | - | - | - |
| Jacobs levy equity management | - | - | - |
| Loring wolcott & coolidge fiduciary advisors llp/ma | - | - | - |
| Hexagon capital partners | 2.00 | - | $17.00 |
| Proshare advisors | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Nelson, van denburg & campbell wealth management group | 356.00 | 0.00% | 356.00 |
| Versant capital management | 123.00 | 0.00% | 123.00 |
| Eversource wealth advisors | 63.00 | - | 63.00 |
| Ifp advisors | 1.00K | - | - |
| Hexagon capital partners | 2.00 | - | -20.00 |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -15.36M |
| Blackrock | - | - | -14.80M |
| Morgan stanley | - | - | -14.44M |
| Vanguard group | - | - | -9.37M |
| Soleus capital management | - | - | -9.24M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Versant capital management | 123.00 | 0.00% | 123.00 | $2.07K |
| Eversource wealth advisors | 63.00 | - | 63.00 | $667.00 |
Sold Out
| Holder | Change |
|---|---|
| Loring wolcott & coolidge fiduciary advisors llp/ma | -27.00 |
| Nisa investment advisors | -432.00 |
| Mather group, llc. | -450.00 |
| Ronald blue trust | -500.00 |
| Continuum advisory | -584.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 4 | -55.56% | 733 | -94.24% | - | 7854.79% | 1 | -50.00% | - | -100.00% |
| Jun 30, 2024 | 9 | -92.62% | 12,725 | -99.99% | - | 0.00% | 2 | -96.00% | 5 | -87.18% |
| Mar 31, 2024 | 122 | 3.39% | 111,001,285 | 4.17% | 63 | 1.69% | 50 | -9.09% | 39 | 30.00% |
| Dec 31, 2023 | 118 | 5.36% | 106,553,972 | 0.27% | 61 | 1.65% | 55 | 30.95% | 30 | -14.29% |
| Sep 30, 2023 | 112 | -7.44% | 106,263,944 | -3.96% | 60 | 1.50% | 42 | 10.53% | 35 | -25.53% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Invesco Dorsey Wright SmallCap Momt ETF | 1.09M | 6.18% | 1.97K |
| Vanguard Total Stock Mkt Idx Inv | 548.78K | 3.12% | - |
| iShares Russell 2000 ETF | 483.64K | 2.75% | -1.85K |
| Vanguard Institutional Extnd Mkt Idx Tr | 264.45K | 1.50% | 6.31K |
| Fidelity Small Cap Index | 177.08K | 1.01% | -127.00 |
| Delaware Healthcare I | 160.00K | 0.91% | - |
| Macquarie Healthcare I | 160.00K | 0.91% | - |
| iShares Russell 2000 Growth ETF | 128.43K | 0.73% | - |
| Zacks Small Cap Equity Strategy | 128.39K | 0.73% | 128.39K |
| iShares Biotechnology ETF | 111.69K | 0.63% | -805.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 05, 2024 | Santos David A | EVP, Chief Commercial Officer | Sell | $10.17K |
| Feb 02, 2024 | Santos David A | EVP, Chief Commercial Officer | Sell | $6.33K |
| Feb 02, 2024 | Schorno Dean L | EVP & Chief Financial Officer | Sell | $6.33K |
| Feb 05, 2024 | Schorno Dean L | EVP & Chief Financial Officer | Sell | $8.01K |
| Feb 02, 2024 | RODRIGUEZ RAUL R | CEO, President | Sell | $25.26K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | 6 |
| 2023 Q2 | - | - |
RIGL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools